Monday, 16 September 2019

Drug Discovery News

  • Pradaxa gets EU approval for DVT

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2014

    Singapore: Boehringer Ingelheim has recieved Euroean approval for Pradaxa (dabigatran etexilate) for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary e...Read more

  • AstraZeneca, LegoChem drug to curb superbugs

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

    Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat drug-resistant bacterial infections. The treatment will potentially ...Read more

  • Big pharma yet to warm up to drug resistance

    Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: Drug resistance and patent expiries are demanding that the antibacterial drug market moves forward soon, but a current lack of interest among pharmaceutical companies has led to ...Read more

  • Cancer Therapeutics reveals new targeted drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2012

    Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatments for cancer, has validated the performance of a new targeted drug, ...Read more

  • Eisai gets WHO prequalification, will donate 2.2 bn doses

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of elephantiasis, and the Japanese firm has committed to donate 2.2 billio...Read more

  • Bayer and Sanofi battle to cure colorectal cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Oct, 2012

    Singapore: Bayer's Stivarga (regorafenib) became the second drug to have been approved in the past two months by the US FDA on September 27 for the treatment of metastatic colorectal cancer...Read more

  • New antibody-based drug to cure diabetes

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2012

    Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and reverse its progression in animal models of the disease. The research has b...Read more

  • Novartis oncology president steps down

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jan, 2014

    Singapore: Novartis oncology president, Mr Hervé Hoppenot, has stepped down from the position to pursue a career opportunity outside the organization. Dr Alessandro Riva, Global Head, N...Read more

  • Hodgkin lymphoma therapy may lead to other cancers

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2013

    Singapore: Hodgkin lymphoma survivors, who received certain radiation and chemotherapy regimens, were at increased risk of subsequently developing stomach cancer, according to a study by sc...Read more

  • Phase III data: STELARA reduces active psoriatic arthritis

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: A study by Janssen Research and Development revealed that patients with active psoriatic arthritis, who were treated using Centocor's STELARA (ustekinumab), witnessed substantial...Read more

  • Lonza, BioWa sign research agreements with Pfizer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Swiss chemicals and drug company Lonza and USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko Kogyo, have entered into research agreements with Pfizer, allowing th...Read more

  • FDA recommends Takeda's drug for Chrohn's disease

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: A joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committees of the United States (U.S.) Food and Drug Administration (FDA) ha...Read more

  • Patrys gets regulatory approval for Multiple Myeloma trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2012

    Singapore: Australia Patrys, a clinical stage biopharmaceutical company, has received approval to commence its planned Phase I/IIa multiple myeloma trial with lead product PAT-SM6. The plan...Read more

  • Novartis follows Time Warner, Twitter to join malaria campaign

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

    Singapore: Novartis and Malaria No More, a leading global charity to end malaria deaths, are joining forces on the Power of One campaign to help close the treatment gap and accelerate progr...Read more

  • NIH: Alcohol addiction depends on gene combination

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: An experimental treatment for alcohol dependence works better in individuals who possess specific combinations of genes that regulate the function and binding of serotonin, a bra...Read more

  • Merck partners with Kenya research centre

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2014

    Singapore: Merck has partnered with Kenya Medical Research Institution (KEMRI) for scientific research and development projects, programs and activities focused on malaria and schistosomias...Read more

  • Shionogi partners with six Irish universities

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for an R&D partnership with six Irish universities, under the compan...Read more

  • Merck alzheimer's trial is a success

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

    Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study showing a dose-dependent decrease in ß amyloid levels in cerebral spi...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls